Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure

American Journal of Cardiology

Volumn 90, Issue 11, 2002, Pages 1226-1230

  Genth Zotz, Sabine ^a,b,d   Von Haehling, Stephan ^a,c   Bolger, Aidan P ^a   Kalra, Paul R ^a   Wensel, Roland ^a,c   Coats, Andrew J S ^a   Anker, Stefan D ^a,c  

^a NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

^c MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^d Inst Cardiol   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTOXIN; RECEPTOR SUBTYPE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ADULT; AGED; ARTICLE; CACHEXIA; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; DISEASE CLASSIFICATION; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; AGED; CACHEXIA; ENDOTOXINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036890211     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(02)02839-4     Document Type: Article

References (18)

1. Anker S.D., Egerer K.R., Volk H.D., Kox W.J., Poole-Wilson P.A., Coats A.J. Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol. 79:1997;1426-1430.
2. Niebauer J., Volk H.D., Kemp M., Dominguez M., Schumann R.R., Rauchhaus M., Poole-Wilson P.A., Coats A.J.S., Anker S.D. Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet. 353:1999;1838-1842.
3. Lequier L.L., Nikaidoh H., Leonard S.R., Bokovoy J.L., White M.L., Scannon P.J., Giroir B.P. Preoperative and postoperative endotoxemia in children with congenital heart disease. Chest. 117:2000;1706-1712.
4. Matsumori A., Shioi T., Yamada T., Matsui S., Sasayama S. Vesnarinone, a new inotropic agent, inhibits cytokine production by stimulated human blood from patients with heart failure. Circulation. 89:1994;955-958.
5. Shimokawa H., Kuroiwa-Matsumoto M., Takeshita A. Cytokine generation capacities of monocytes are reduced in patients with severe heart failure. Am Heart J. 136:1998;991-1002.
6. Anker S.D., Ponikowski P., Varney S., Chua T.P., Clark A.L., Webb-Peploe K.M., Harrington D., Kox W.J., Poole-Wilson P.A., Coats A.J. Wasting as independent risk factor for mortality in chronic heart failure. Lancet. 349:1997;1050-1053.
7. Stordeur P., Poulin L.F., Craciun L., Zhou L., Schandene L., de Lavareille A., Goriely S., Goldman M. Cytokine mRNA quantification by real-time PCR. J Immunol Methods. 259:2001;55-64.
8. Vonhof S., Brost B., Stille-Siegener M., Grumbach I.M., Kreuzer H., Figulla H.R. Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy. Int J Cardiol. 63:1998;237-244.
9. Yokota M., Kambayashi J., Tanaka T., Tsujinaka T., Sakon M., Mori T. A simple turbidimetric time assay of the endotoxin in plasma. J Biochem Biophys Methods. 18:1989;97-104.
10. Michie H.R., Manogue K.R., Spriggs D.R., Revhaug A., O'Dwyer S., Dinarello C.A., Cerami A., Wolff S.M., Wilmore D.W. Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med. 318:1988;1481-1486.
11. Labeta M.O., Durieux J.J., Spagnoli G., Fernandez N., Wijdenes J., Herrmann R. CD14 and tolerance to lipopolysaccharide biochemical and functional analysis . Immunology. 80:1993;415-423.
12. Medzhitov R., Janeway C. Jr. Innate immunity. N Engl J Med. 343:2000;338-344.
13. Wright S.D., Ramos R.A., Tobias P.S., Ulevitch R.J., Mathison J.C. CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science. 249:1990;1431-1433.
14. Rauchhaus M., Doehner W., Francis D.P., Davos C., Kemp M., Liebenthal C., Niebauer J., Hooper J., Volk H.D., Coats A.J., Anker S.D. Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation. 102:2000;3060-3067.
15. De Werra I., Zanetti G., Jaccard C., Chiolero R., Schaller M.D., Yersin B., Glauser M.P., Calandra T., Heumann D. CD14 expression on monocytes and TNF-α production in patients with septic shock, cardiogenic shock or bacterial pneumonia. Swiss Med Wkly. 131:2001;35-40.
16. Randow F., Syrbe U., Meisel C., Krausch D., Zuckermann H., Platzer C., Volk H.D. Mechanism of endotoxin desensitization involvement of interleukin-10 and transforming growth factor beta . J Exp Med. 18:1995;1887-1892.
17. Bolger A.P., Sharma R., von Haehling S., Doehner W., Oliver B., Rauchhaus M., Coats A.J., Adcock I.M., Anker S.D. Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. Am J Cardiol. 90:2002;384-389.
18. von Haehling S., Genth-Zotz S., Anker S.D., Volk H.D. Cachexia: a therapeutic approach beyond cytokine antagonism. Int J Cardiol. 85:2002;173-183.